Senior executive brings deep financial planning and analysis experience to leadership team. DALLAS – Form Bio, the breakthrough computational life sciences platform, today announced the appointment of Linda Murray as Chief Financial Officer. “We are excited to announce this important addition to Form Bio’s leadership team as we enter an exciting time in our development and evolution; […]
CALGARY, AB — Nanalysis Scientific Corp. (“the Company”, TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, announces the appointment of Randall McRae to Chief Financial Officer. “Randall has done an outstanding job since stepping into the interim role over seven months ago,” said Sean Krakiwsky, Founder and CEO of Nanalysis. […]
MARLBOROUGH, Mass. — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Jennifer Kamocsay as General Counsel. Ms. Kamocsay will oversee all company legal activities and provide strategic guidance and corporate governance oversight. “We are excited to welcome Jennifer to our leadership team,” said Brian McKelligon, Chief Executive Officer […]
Distinguished California Institue of Technology Professor and Howard Hughes Medical Institute Investigator Joins Kytopen Scientific Board to Provide Strategic Guidance on Genome Engineering Platform Development CAMBRIDGE, Mass. — Kytopen, an MIT-spin out and biotechnology company leading advancements in high-throughput cellular and genome engineering platforms, today announced the addition of leading chemical and medical engineering expert Mikhail Shapiro, Ph.D. to […]
OXFORD, England & SAN DIEGO — ONI, the biotechnology company broadly enabling the ability to observe single molecules in living cells with its desktop Nanoimager microscopy platform, today announced that Paul Scagnetti has been appointed as the company’s new CEO, effective February 27, 2023. Along with this leadership change, ONI will begin to implement a […]
Dr Klaus Endress to leave the Supervisory Board by the end of the year; Matthias Altendorf named as successor; Dr Peter Selders will become CEO As previously announced, Dr Klaus Endress will give up his responsibilities as president of the Supervisory Board. He is to be succeeded by CEO Matthias Altendorf. The new CEO of […]
John Battles joins executive team to lead and expand product and technical opportunities Genomenon®, an AI-driven genomics company, announced today that John Battles has been appointed Vice President of Engineering. Battles will be responsible for leading the technical vision and implementation to deliver leading edge precision medicine solutions. Before joining Genomenon, Battles led many successful […]
After ten years with LGC, initially as Chief Executive Officer and most recently as Non-Executive Chair, Tim Robinson has announced that, as planned, he will be retiring from LGC to focus on public service and philanthropy. Tim will take up new roles as Lead Non-Executive Director of the UK Home Office and as a Trustee […]
WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences tools industry leader Martin D. Madaus. Dr. Madaus brings to the Repligen board over 25 years of industry experience, including five years as Chairman, President and Chief Executive Officer of Millipore Corporation, where he was integral to […]
Appointment follows successful expansion of operations in China and transition to direct sales model Supports next phase in H.E.L’s development as China becomes significant contributor to commercial growth London, UK: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced the appointment Wang Zilong (Allen Wang) […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
